X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs LUPIN LTD - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD LUPIN LTD MERCK LTD/
LUPIN LTD
 
P/E (TTM) x 34.6 20.0 173.3% View Chart
P/BV x 3.9 2.7 143.1% View Chart
Dividend Yield % 0.7 0.9 78.8%  

Financials

 MERCK LTD   LUPIN LTD
EQUITY SHARE DATA
    MERCK LTD
Dec-16
LUPIN LTD
Mar-17
MERCK LTD/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1,0601,750 60.6%   
Low Rs6231,384 45.0%   
Sales per share (Unadj.) Rs632.4387.4 163.2%  
Earnings per share (Unadj.) Rs45.756.6 80.7%  
Cash flow per share (Unadj.) Rs62.376.8 81.1%  
Dividends per share (Unadj.) Rs11.007.50 146.7%  
Dividend yield (eoy) %1.30.5 273.1%  
Book value per share (Unadj.) Rs388.8298.9 130.1%  
Shares outstanding (eoy) m16.60451.58 3.7%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x1.34.0 32.9%   
Avg P/E ratio x18.427.7 66.5%  
P/CF ratio (eoy) x13.520.4 66.2%  
Price / Book Value ratio x2.25.2 41.3%  
Dividend payout %24.113.2 181.7%   
Avg Mkt Cap Rs m13,969707,513 2.0%   
No. of employees `0001.616.8 9.4%   
Total wages/salary Rs m1,48728,495 5.2%   
Avg. sales/employee Rs Th6,631.910,418.3 63.7%   
Avg. wages/employee Rs Th939.21,697.0 55.3%   
Avg. net profit/employee Rs Th479.41,523.0 31.5%   
INCOME DATA
Net Sales Rs m10,498174,943 6.0%  
Other income Rs m2421,065 22.8%   
Total revenues Rs m10,741176,008 6.1%   
Gross profit Rs m1,13544,931 2.5%  
Depreciation Rs m2769,122 3.0%   
Interest Rs m01,525 0.0%   
Profit before tax Rs m1,10235,349 3.1%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3439,785 3.5%   
Profit after tax Rs m75925,575 3.0%  
Gross profit margin %10.825.7 42.1%  
Effective tax rate %31.127.7 112.5%   
Net profit margin %7.214.6 49.4%  
BALANCE SHEET DATA
Current assets Rs m6,410119,542 5.4%   
Current liabilities Rs m8,82861,206 14.4%   
Net working cap to sales %-23.033.3 -69.1%  
Current ratio x0.72.0 37.2%  
Inventory Days Days5876 75.9%  
Debtors Days Days3890 42.7%  
Net fixed assets Rs m1,406131,660 1.1%   
Share capital Rs m166903 18.4%   
"Free" reserves Rs m6,286134,073 4.7%   
Net worth Rs m6,455134,976 4.8%   
Long term debt Rs m056,478 0.0%   
Total assets Rs m8,828266,073 3.3%  
Interest coverage xNM24.2-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.7 180.9%   
Return on assets %8.610.2 84.4%  
Return on equity %11.818.9 62.1%  
Return on capital %17.119.3 88.6%  
Exports to sales %8.30-   
Imports to sales %21.00-   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209NA-   
Fx inflow Rs m95981,885 1.2%   
Fx outflow Rs m2,61221,506 12.1%   
Net fx Rs m-1,65360,378 -2.7%   
CASH FLOW
From Operations Rs m1,07041,148 2.6%  
From Investments Rs m-750-25,287 3.0%  
From Financial Activity Rs m-1504,332 -3.5%  
Net Cashflow Rs m17120,193 0.8%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 51.8 0.2 25,900.0%  
Indian inst/Mut Fund % 18.2 11.3 161.1%  
FIIs % 1.0 31.9 3.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 10.1 288.1%  
Shareholders   28,591 98,259 29.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SHASUN PHARMA  CIPLA  ASTRAZENECA PHARMA  SUVEN LIFE  STERLING BIOTECH  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Firm; Healthcare & Metal Stocks Gain(09:30 am)

Asian stocks are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.17% while the Hang Seng is up 0.95%. The Nikkei 225 is trading up by 0.4%.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 23, 2018 10:19 AM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS